Mahacort DZ 6 Tablet contains Deflazacort 6 mg, a synthetic corticosteroid with potent anti-inflammatory and immunosuppressive properties. It is primarily indicated for the management of various inflammatory and autoimmune conditions such as rheumatoid arthritis, systemic lupus erythematosus, allergic disorders, and certain dermatological diseases. Deflazacort exerts its therapeutic effects by modulating the immune response and reducing the release of inflammatory mediators, thereby alleviating symptoms such as swelling, pain, and redness. Additionally, it is utilized in the treatment of certain muscular dystrophies to improve muscle strength and function. Mahacort DZ 6 Tablet should be administered under medical supervision, with dosage tailored to the specific condition and patient response. Caution is advised in patients with infections, diabetes, hypertension, osteoporosis, or peptic ulcer disease, as corticosteroids may exacerbate these conditions. Common side effects include gastrointestinal disturbances, increased susceptibility to infections, mood changes, and elevated blood glucose levels. Long-term use requires monitoring for potential adrenal suppression and other systemic effects. Abrupt discontinuation should be avoided to prevent withdrawal symptoms. Overall, Mahacort DZ 6 Tablet is an effective therapeutic agent for controlling inflammation and modulating immune activity when used appropriately.